Turn Therapeutics develops topical drug candidates for skin conditions and licenses wound care medical devices to partners. It last closed at $8.10 on Nov 20, down 6.31% on the day. The next earnings report for TTRX is expected around Tue, Mar 30, 2027, after the close. For the quarter ended Sep 2026, TTRX reported EPS of -$0.21. Over its last 5 reports the stock moved an average of 4.4% the session after earnings. Over the last 12 months TTRX insiders bought $109K of stock on the open market and sold $0, according to SEC Form 4 filings.
AI Auto Pilots
Is TTRX in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold TTRX.
Close to close, the session after each report, adjusted for splits. Past moves are no guide to the next one.
StreetAlpha callBullish64%
OPTIONS
+2
DARK POOL
+1
HISTORY
0
TECHNICAL
+1
StreetAlpha's call on TTRXStart your 7 day free trial to see StreetAlpha's call before the report, with the options flow, dark pool, history and technical scores behind it.Sign up freeSign in
TTRX · as of the Nov 20 close · updated each morning
Pullback inside a longer uptrend, nearing oversold
The stock is 19% below its 20 day and 40% below its 50 day average. It is 9% above its 200 day average, so the longer trend is still up. Momentum is weak (RSI 35), near oversold. The nearest support is the Pivot S1 at $7.59, and the nearest resistance the Pivot at $8.39.
Short trendBearish
Long trendBullish
MomentumWeak
StretchNear oversold
VolatilityHigh, 12.8%/day
Key levels
$16.4552 week high+103.1%
$11.3250 day average+39.8%
$10.49100 day average+29.5%
$10.48Swing high (Jul 21)+29.4%
$9.6620 day average+19.3%
$8.90Pivot R1+9.9%
$8.39Pivot+3.6%
$8.10Last close
$7.59Pivot S1−6.3%
$7.37200 day average−9.0%
$7.17Swing low (Jul 29)−11.5%
$2.5752 week low−68.3%
Indicators
RSI (14)
34.95
Weak, oversold below 30
Neutral
MACD
-0.67
Below its signal line
Bearish
Stochastic
16.6
Near the bottom of its range
Oversold
ADX (14)
25.6
Trending down
Williams %R
-93.8
Oversold below −80, overbought above −20
Oversold
CCI (20)
-134.7
Oversold below −100, overbought above 100
Oversold
Rate of change
−14.6%
Change over 10 sessions
Bearish
ATR (14)
$1.04
Typical daily range, 12.8% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Above
Rising
Short trendBullish
Long trendNot enough history
MomentumWeak
StretchNormal
VolatilityNormal, 24.5%/day
Key levels
$16.4552 week high+103.1%
$11.3250 day average+39.8%
$10.49100 day average+29.5%
$10.48Swing high (Jul 21)+29.4%
$9.6620 day average+19.3%
$8.90Pivot R1+9.9%
$8.39Pivot+3.6%
$8.10Last close
$7.59Pivot S1−6.3%
$7.37200 day average−9.0%
$7.17Swing low (Jul 29)−11.5%
$2.5752 week low−68.3%
Indicators
RSI (14)
44.77
Middle of its range
Neutral
MACD
0.83
Below its signal line
Bearish
Stochastic
10.6
Near the bottom of its range
Oversold
ADX (14)
44.6
Strong uptrend
Williams %R
-97.6
Oversold below −80, overbought above −20
Oversold
CCI (20)
-95.3
Oversold below −100, overbought above 100
Neutral
Rate of change
−36.2%
Change over 10 sessions
Bearish
ATR (14)
$1.98
Typical daily range, 24.5% of price
MA 10Below
MA 20Below
MA 50Above
MA 100–
MA 200–
What happened before, for TTRX
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
What happened before
See how TTRX did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
AI Day Trader
Watch Claude day trade the open, live.
Every session it trades SPY, QQQ, IWM and two daily stock picks, with each call logged before the move.
Whale options flow for TTRXHow many large options trades hit TTRX, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in
No whale options trades in TTRX in the last 90 days.
From SEC Form 4 filings by TTRX's officers, directors and 10% owners. Open market buys and sales only; option exercises, gifts, awards and tax withholding are left out. Not investment advice.
AI Auto Pilots
Paper trading
StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether TTRX is in one of them and how their past TTRX trades turned out.
Turn Therapeutics is a drug development company based in Westlake Village, California. It is developing GX-03, a topical treatment for inflammatory skin conditions, with programs aimed at moderate to severe eczema and nail fungus, known as onychomycosis. The company also licenses wound care and dermatitis medical devices to commercial partners, including Medline. Its drug candidate uses polyhexanide, a polymer with a long history of use in wound care.